<DOC>
	<DOCNO>NCT00233714</DOCNO>
	<brief_summary>The main objective study assess safety effectiveness double dose sirolimus-eluting Bx VELOCITY stent diabetic patient de novo native coronary lesion , compare single dose sirolimus-eluting Bx VELOCITYâ„¢ stent .</brief_summary>
	<brief_title>Double Single Dose Sirolimus-Eluting Stents Diabetic Patients With de Novo Coronary Artery Lesions</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . The patient must minimum 18 year age ; 2 . Patients must previously diagnose diabetes document treatment insulin , oral medication , diet minimum 3 month ; 3 . Diagnosis angina pectoris define Canadian Cardiovascular Society Classification ( CCS I , II , III , IV ) OR unstable angina pectoris ( Braunwald Classification B &amp; C , IIIIII ) OR patient document silent ischemia ; 4 . Treatment one lesion native coronary artery . The treated lesion one high % diameter stenosis visual estimate . Additional study stent may use procedural complication dissection . Multivessel treatment permissible nontarget vessel ; however , additional lesion may treat commercial stent . If nontarget lesion treat commercial stent index procedure , must successfully treat prior study lesion ; 5 . The target vessel 2.5 mm 3.5mm diameter ( visual estimate ) ; 6 . The target lesion &lt; 30 mm length ( visual estimate ) locate native coronary artery ; 7 . Target lesion stenosis &gt; 50 % &lt; 100 % ( TIMI I ) ( visual estimate ) ; 1 . Patient experience Qwave nonQwave myocardial infarction document total CK &gt; 2 time normal within precede 24 hour CK CKMB enzymes remain normal time treatment ; 2 . Patients admit treatment diabetic ketoacidosis &gt; 2 time past six month ( Brittle Diabetics ) ; 3 . Ejection fraction 30 % ; 4 . Impaired renal function ( creatinine &gt; 2.0 mg/dL ) ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>